Peregrine Pharma (PPHM) Misses Q1 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- US stock futures muted as oil stays above $100 ahead of earnings
- Oil prices fluctuate on Trump's Russian diesel comments, attacks on Saudi
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
Tweet
Share
E-mailGet Alerts PPHM Hot Sheet
Price: $0.61 --0%
Financial Fact:
LOSS FROM OPERATIONS: -11.08M
Today's EPS Names:
NRIX, VFS, GLDG, More
Financial Fact:
LOSS FROM OPERATIONS: -11.08M
Today's EPS Names:
NRIX, VFS, GLDG, More
Join SI Premium – FREE
Peregrine Pharma (NASDAQ: PPHM) reported Q1 EPS of ($0.05), $0.01 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $5.61 million versus the consensus estimate of $13.09 million.
GUIDANCE:
Peregrine Pharma sees Q2 2017 revenue of $20 million, versus the consensus of $12.5 million.
- Company Reaffirms Revenue Projection of $50 - $55 Million for Full FY 2017 with Growing Backlog of Business
For earnings history and earnings-related data on Peregrine Pharma (PPHM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BTIG Downgrades UWM Holdings Corp. (UWMC) to Neutral
- AngioDynamics (ANGO) Tops Q1 EPS by 7c, Beats on Revenue; Offers F27 Revenue Guidance
- Delta Air Lines (DAL) Misses Q3 EPS by 20c, Beats on Revenue; Cuts FY EPS Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
